EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management

Radha Gopalaswamy iD, Selvakumar Subbian iD

Clinical Microbiology Reviews · 12.03.2026 · 39 (1)

DOI: 10.1128/cmr.00194-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.03.2026. Verfasst von Radha Gopalaswamy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Madurai Kamaraj University, Madurai, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant, Drug Resistance, Bacterial. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global resurgence of drug-resistant tuberculosis (DR-TB) presents a formidable challenge to public health, driven by a complex interplay of mycobacterial evolution, dynamics and outcomes of host-pathogen interactions and systemic gaps in diagnosis and treatment strategies. This comprehensive review delineates the multifactorial basis of antimicrobial resistance (AMR) in Mycobacterium tuberculosis (Mtb), integrating molecular, immunological, and pharmacological perspectives to inform next-generation strategies for effective TB control. We reconceptualize TB as a dynamic clinical spectrum—ranging from asymptomatic infection to overt disease—shaped by granuloma biology and bacterial adaptation. This spectrum underpins both diagnostic ambiguity and therapeutic failure, particularly in the context of phenotypic drug tolerance/resistance to current anti-TB drugs. We discuss Mtb’s intrinsic and extrinsic resistance mechanisms, including the lipid-rich cell envelope, efflux systems, and enzymatic drug modification, which are compounded by acquired mutations that disrupt drug activation, alter targets, and confer cross-resistance. These adaptations are further potentiated by granuloma-induced pharmacokinetic heterogeneity and host-induced metabolic quiescence. We highlight the emerging role of therapeutic drug monitoring and pharmacokinetic/pharmacodynamic modeling in optimizing individualized therapy, particularly for novel regimens incorporating bedaquiline, pretomanid, and linezolid. Moreover, we underscore the diagnostic limitations in detecting heteroresistance and early-stage disease, advocating for expanded deployment of advanced and targeted molecular diagnostic modalities. Finally, we propose a paradigm shift toward integrated, precision-based TB management, leveraging host-directed therapies, biofilm-disrupting agents, and real-time pharmacokinetics-guided dosing to preempt resistance emergence and improve clinical outcomes. This review provides a translational framework for addressing the biological and operational complexities of DR-TB in the era of AMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantDrug Resistance, BacterialTuberculosisHumansHost-Pathogen Interactions

Stichwörter der Autor:innen

CRISPR/CasMALDI-ToF/MSantimicrobial resistancebiofilmdrug metabolismdrug repurposinggene mutationsgranulomatherapeutic drug monitoring

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Madurai Kamaraj University, Madurai, India.
  • Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.

ORCID-Profile: Radha Gopalaswamy, Selvakumar Subbian

Zitieren

APA

Gopalaswamy, R., & Subbian, S. (2026). The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management. Clinical Microbiology Reviews, 39(1). https://doi.org/10.1128/cmr.00194-25

Vancouver

Gopalaswamy R, Subbian S. The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management. Clinical Microbiology Reviews. 2026;39(1). doi:10.1128/cmr.00194-25

BibTeX
@article{Gopalaswamy2026,
  author = {Gopalaswamy, Radha and Subbian, Selvakumar},
  title = {The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management},
  journal = {Clinical Microbiology Reviews},
  year = {2026},
  volume = {39},
  number = {1},
  doi = {10.1128/cmr.00194-25}
}
Kostenlos starten →